25429309|t|Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study.
25429309|a|INTRODUCTION: The biological basis of cognitive impairment in parkinsonian diseases is believed to be multifactorial. We investigated the contribution of dopamine deficiency to cognition in Parkinson disease (PD) and dementia with Lewy bodies (DLB) with dopamine transporter (DAT) imaging. METHODS: We acquired (11)C altropane PET, magnetic resonance imaging and cognitive testing in 19 nondemented subjects with PD, 10 DLB and 17 healthy control subjects (HCS). We analyzed DAT concentration in putamen, caudate, anterior cingulate (AC), orbitofrontal and prefrontal regions, using the Standardized Uptake Volume Ratio with partial volume correction, and we related DAT concentration and global cortical thickness to neuropsychological performance. RESULTS: DAT concentration in putamen and in caudate were similar in PD and DLB groups and significantly lower than in HCS. Reduced caudate DAT concentration was associated with worse Clinical Dementia Rating Scale-sum of boxes (CDR-SB) scores and visuospatial skills in DLB but not in PD or HCS groups. Adjusting for putamen DAT concentration, as a measure of severity of motor disease, caudate DAT concentration was lower in DLB than in PD. Higher AC DAT concentration was associated with lower putamen DAT concentration in DLB and with higher putamen DAT concentration in PD. Higher AC DAT concentration in DLB correlated with greater impairment in semantic memory and language. CONCLUSIONS: Caudate and AC dopamine dysfunction contribute in opposing directions to cognitive impairment in DLB.
25429309	27	47	dopamine transporter	Gene	6531
25429309	78	96	Lewy body diseases	Disease	MESH:D020961
25429309	101	116	(11)C altropane	Chemical	-
25429309	191	211	cognitive impairment	Disease	MESH:D003072
25429309	215	236	parkinsonian diseases	Disease	MESH:D010300
25429309	307	326	dopamine deficiency	Disease	MESH:C567730
25429309	343	360	Parkinson disease	Disease	MESH:D010300
25429309	362	364	PD	Disease	MESH:D010300
25429309	370	395	dementia with Lewy bodies	Disease	MESH:D020961
25429309	397	400	DLB	Disease	MESH:D020961
25429309	407	427	dopamine transporter	Gene	6531
25429309	429	432	DAT	Gene	6531
25429309	464	479	(11)C altropane	Chemical	-
25429309	566	568	PD	Disease	MESH:D010300
25429309	573	576	DLB	Disease	MESH:D020961
25429309	628	631	DAT	Gene	6531
25429309	820	823	DAT	Gene	6531
25429309	912	915	DAT	Gene	6531
25429309	972	974	PD	Disease	MESH:D010300
25429309	979	982	DLB	Disease	MESH:D020961
25429309	1043	1046	DAT	Gene	6531
25429309	1096	1104	Dementia	Disease	MESH:D003704
25429309	1174	1177	DLB	Disease	MESH:D020961
25429309	1189	1191	PD	Disease	MESH:D010300
25429309	1229	1232	DAT	Gene	6531
25429309	1276	1289	motor disease	Disease	MESH:D004194
25429309	1299	1302	DAT	Gene	6531
25429309	1330	1333	DLB	Disease	MESH:D020961
25429309	1342	1344	PD	Disease	MESH:D010300
25429309	1356	1359	DAT	Gene	6531
25429309	1408	1411	DAT	Gene	6531
25429309	1429	1432	DLB	Disease	MESH:D020961
25429309	1457	1460	DAT	Gene	6531
25429309	1478	1480	PD	Disease	MESH:D010300
25429309	1492	1495	DAT	Gene	6531
25429309	1513	1516	DLB	Disease	MESH:D020961
25429309	1541	1583	impairment in semantic memory and language	Disease	MESH:D008569
25429309	1613	1621	dopamine	Chemical	MESH:D004298
25429309	1671	1691	cognitive impairment	Disease	MESH:D003072
25429309	1695	1698	DLB	Disease	MESH:D020961
25429309	Positive_Correlation	MESH:D008569	6531
25429309	Association	MESH:D020961	6531
25429309	Association	MESH:C567730	6531
25429309	Association	MESH:D004194	6531
25429309	Association	MESH:D004298	MESH:D020961
25429309	Association	MESH:D004298	MESH:D003072
25429309	Association	MESH:D010300	6531

